Literature DB >> 10468189

Melanocyte melanin augments sparfloxacin-induced phototoxicity.

H Hamanaka1, H Mizutani, K Asahig, M Shimizu.   

Abstract

Quinolone has become one of the common causative agents of drug-induced photosensitive dermatitis, and its phototoxicity has now become a clinical issue. The mechanisms of long-lasting phototoxicity induced by sparfloxacin (SPFX) were investigated using melanotic and amelanotic melanoma cell lines. The sensitivities to SPFX and UVA irradiation up to 6 J/cm2 of both cells were not significantly different. However, the melanotic melanoma cell cultured with 1-150 microg/ml of SPFX showed significantly higher sensitivity to UVA irradiation compared with that of the amelanotic melanoma cell. By pulse culture with SPFX, the bound SPFX level of melanotic cell line was 10-20 times higher than that of the amelanotic cell line. These data strongly suggest that the melanin in melanocytes and keratinocytes accumulates the antibacterial quinolone and increases its tissue concentration in the basal epidermis and contributes to the long-lasting photo-injury and liquefaction degeneration of the basal cells in antibiotic quinolone phototoxic dermatitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468189     DOI: 10.1016/s0923-1811(99)00010-9

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  3 in total

1.  Oral Fluoroquinolones and the Risk of Uveitis.

Authors:  Harpal Singh Sandhu; Alexander J Brucker; Liyuan Ma; Brian L VanderBeek
Journal:  JAMA Ophthalmol       Date:  2016-01       Impact factor: 7.389

2.  Changes in the Oxidation-Reduction State of Human Dermal Fibroblasts as an Effect of Lomefloxacin Phototoxic Action.

Authors:  Justyna Kowalska; Klaudia Banach; Zuzanna Rzepka; Jakub Rok; Marta Karkoszka; Dorota Wrześniok
Journal:  Cells       Date:  2022-06-19       Impact factor: 7.666

3.  Exposure to phototoxic NSAIDs and quinolones is associated with an increased risk of melanoma.

Authors:  Satu J Siiskonen; Els R Koomen; Loes E Visser; Ron M C Herings; Henk-Jan Guchelaar; Bruno H Ch Stricker; Tamar E C Nijsten
Journal:  Eur J Clin Pharmacol       Date:  2013-03-08       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.